IL15 and neoplasm: Mice treated with the combination of anti-PD-1mAb (i.p.), and two doses of IL-15 complexes (i.t.)showed reduced tumor growth compared to tumors of mice in both single modality treatments and the control (PBS/IgG isotype) group (Figure 1E and Supplemental Figure S1J).